122 related articles for article (PubMed ID: 8673116)
1. Natural gene therapy and the Darwinian legacy.
Youssoufian H
Nat Genet; 1996 Jul; 13(3):255-6. PubMed ID: 8673116
[No Abstract] [Full Text] [Related]
2. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency.
Hirschhorn R; Yang DR; Puck JM; Huie ML; Jiang CK; Kurlandsky LE
Nat Genet; 1996 Jul; 13(3):290-5. PubMed ID: 8673127
[TBL] [Abstract][Full Text] [Related]
3. Human somatic cell gene therapy.
Bank A
Bioessays; 1996 Dec; 18(12):999-1007. PubMed ID: 8976157
[TBL] [Abstract][Full Text] [Related]
4. Future tense for in utero gene therapy.
Fox JL
Nat Biotechnol; 1998 Nov; 16(11):1002-3. PubMed ID: 9831019
[No Abstract] [Full Text] [Related]
5. Gene therapy for genetic diseases.
Anderson WF
Hum Gene Ther; 1994 Mar; 5(3):281-2. PubMed ID: 8018743
[No Abstract] [Full Text] [Related]
6. [Gene diagnosis and gene therapy].
Kamatani N
Nihon Naika Gakkai Zasshi; 1993 Apr; 82(4):598-604. PubMed ID: 8340672
[No Abstract] [Full Text] [Related]
7. [Adenosine deaminase deficiency].
Sakiyama Y
Ryoikibetsu Shokogun Shirizu; 2000; (32):32-4. PubMed ID: 11212730
[No Abstract] [Full Text] [Related]
8. Update on gene therapy for hereditary hematological disorders.
Herzog RW; Arruda VR
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):215-32. PubMed ID: 15030282
[TBL] [Abstract][Full Text] [Related]
9. Human gene therapy: the future is now, the promise yet to come.
Steinberg MH
Blood Cells; 1991; 17(2):417-24. PubMed ID: 1912601
[No Abstract] [Full Text] [Related]
10. In vivo reversion to normal of inherited mutations in humans.
Hirschhorn R
J Med Genet; 2003 Oct; 40(10):721-8. PubMed ID: 14569115
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy in recovery phase.
Ready T
Nat Med; 2002 May; 8(5):429-30. PubMed ID: 11984571
[No Abstract] [Full Text] [Related]
12. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
13. LMO2 and gene therapy for severe combined immunodeficiency.
Stone BD
N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15195349
[No Abstract] [Full Text] [Related]
14. A small step for gene therapy.
Nat Genet; 1994 Apr; 6(4):323-4. PubMed ID: 8054965
[No Abstract] [Full Text] [Related]
15. [Ten years of gene therapy, and now?].
Nau JY
Rev Med Suisse; 2010 Mar; 6(240):594-5. PubMed ID: 20408466
[No Abstract] [Full Text] [Related]
16. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for genetic diseases.
Kohn DB; Anderson WF; Blaese RM
Cancer Invest; 1989; 7(2):179-92. PubMed ID: 2676086
[No Abstract] [Full Text] [Related]
18. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Cavazzana-Calvo M
Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
[TBL] [Abstract][Full Text] [Related]
19. US panel advises resumption of gene trials.
Fox JL
Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
[No Abstract] [Full Text] [Related]
20. [It is no more about cancer, but it is already about gene therapy].
Jeanteur P
Bull Cancer; 2000 Jun; 87(6):445-6. PubMed ID: 10928794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
